S. 974 - Creating and Restoring Equal Access to Equivalent Samples Act of 2018
- Sponsor:
- Patrick J. Leahy
- Summary:
- A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. (by CRS)
- Status:
- The bill has passed through committee and has been put on a legislative calendar.
Creating and Restoring Equal Access to Equivalent Samples Act of 2018
S. 974 — 115th Congress (2017–2018)
- Summary
- A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products. (by CRS)
- Learn More
- At OpenCongress
- Title
- A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
- Other Titles
- CREATES Act of 2017
- CREATES Act of 2017
- Creating and Restoring Equal Access To Equivalent Samples Act of 2017
- Creating and Restoring Equal Access To Equivalent Samples Act of 2017
- CREATES Act of 2017
- CREATES Act of 2018
- CREATES Act of 2018
- Creating and Restoring Equal Access To Equivalent Samples Act of 2017
- Creating and Restoring Equal Access to Equivalent Samples Act of 2018
- Creating and Restoring Equal Access to Equivalent Samples Act of 2018
- Creating and Restoring Equal Access to Equivalent Samples Act of 2018
- Sponsor
- Patrick J. Leahy
- Co-Sponsors
- Tammy Baldwin
- Richard Blumenthal
- Cory A. Booker
- Sherrod Brown
- Susan M. Collins
- Tom Cotton
- Ted Cruz
- Steve Daines
- Richard J. Durbin
- Joni Ernst
- Dianne Feinstein
- Deb Fischer
- Lindsey Graham
- Chuck Grassley
- Margaret Wood Hassan
- John Kennedy
- Angus S. King, Jr.
- Amy Klobuchar
- Mike Lee
- John McCain
- Claire McCaskill
- Robert Menendez
- Lisa Murkowski
- Rand Paul
- Mike Rounds
- Tina Smith
- Debbie Stabenow
- Jon Tester
- Sheldon Whitehouse
- Todd Young
- Subjects
- Health
- Civil actions and liability
- Drug safety, medical device, and laboratory regulation
- Licensing and registrations
- Prescription drugs
- Product development and innovation
- Related Bills
- Major Actions
Introduced 4/27/2017 Referred to Committee - Bill History
-
There have been no votes on this bill.
Action Date Description Introduced 4/27/2017 4/27/2017 Introduced in Senate 4/27/2017 Read twice and referred to the Committee on the Judiciary. Put on a legislative calendar 6/14/2018 Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably. 6/21/2018 Committee on the Judiciary. Reported by Senator Grassley with an amendment in the nature of a substitute. Without written report. Put on a legislative calendar 6/21/2018 Placed on Senate Legislative Calendar under General Orders. Calendar No. 482. Number Sponsor Date Offered Status
Total contributions given to Senators from interest groups that…
Contributions data source: OpenSecrets.org